| Q33941047 | "Rational vaccine design" for HIV should take into account the adaptive potential of polyreactive antibodies |
| Q33949875 | (19)F NMR reveals multiple conformations at the dimer interface of the nonstructural protein 1 effector domain from influenza A virus |
| Q35686321 | A Barcoding Strategy Enabling Higher-Throughput Library Screening by Microscopy |
| Q37428821 | A proteomic perspective of Sirtuin 6 (SIRT6) phosphorylation and interactions and their dependence on its catalytic activity |
| Q35175356 | Achieving peptide binding specificity and promiscuity by loops: case of the forkhead-associated domain |
| Q30358999 | Advantages of proteins being disordered. |
| Q27670891 | Analysis of the Binding Forces Driving the Tight Interactions between -Lactamase Inhibitory Protein-II (BLIP-II) and Class A -Lactamases |
| Q38248878 | Biological messiness vs. biological genius: Mechanistic aspects and roles of protein promiscuity |
| Q34311852 | Biophysics of protein evolution and evolutionary protein biophysics |
| Q27678611 | Characterization of 14-3-3-ζ Interactions with Integrin Tails |
| Q37895176 | Characterizing weak protein-protein complexes by NMR residual dipolar couplings. |
| Q34947947 | Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53 |
| Q64243664 | Comparative analysis of mutational robustness of the intrinsically disordered viral protein VPg and of its interactor eIF4E |
| Q34254998 | Comparison of tertiary structures of proteins in protein-protein complexes with unbound forms suggests prevalence of allostery in signalling proteins. |
| Q92727507 | Computational Redesign of PD-1 Interface for PD-L1 Ligand Selectivity |
| Q34490108 | Conformational selection underlies recognition of a molybdoenzyme by its dedicated chaperone |
| Q51635711 | Conformational selection underpins recognition of multiple DNA sequences by proteins and consequent functional actions. |
| Q46241352 | Conservation of specificity in two low-specificity proteins. |
| Q36230279 | Contextualizing context for synthetic biology--identifying causes of failure of synthetic biological systems |
| Q41583765 | Counterbalance of ligand- and self-coupled motions characterizes multispecificity of ubiquitin |
| Q41296539 | Crucial roles of single residues in binding affinity, specificity, and promiscuity in the cellulosomal cohesin-dockerin interface |
| Q30416858 | Designing specific protein-protein interactions using computation, experimental library screening, or integrated methods |
| Q52589113 | Directed evolution of broadly crossreactive chemokine-blocking antibodies efficacious in arthritis. |
| Q34083040 | Dissecting allosteric effects of activator-coactivator complexes using a covalent small molecule ligand |
| Q46125144 | Do intrinsically disordered proteins possess high specificity in protein-protein interactions? |
| Q38109928 | Druggable orthosteric and allosteric hot spots to target protein-protein interactions. |
| Q40532268 | Engineering Specificity from Broad to Narrow: Design of a β-Lactamase Inhibitory Protein (BLIP) Variant That Exclusively Binds and Detects KPC β-Lactamase |
| Q35605100 | Ensemble perspective for catalytic promiscuity: calorimetric analysis of the active site conformational landscape of a detoxification enzyme |
| Q92034887 | Estimating dispensable content in the human interactome |
| Q47782190 | Evolutionary diversification of protein-protein interactions by interface add-ons |
| Q27024085 | Functions of the Hsp90 chaperone system: lifting client proteins to new heights |
| Q38370771 | How do disordered regions achieve comparable functions to structured domains? |
| Q38949196 | Identification of productive and futile encounters in an electron transfer protein complex. |
| Q36928945 | Identification of the β-lactamase inhibitor protein-II (BLIP-II) interface residues essential for binding affinity and specificity for class A β-lactamases |
| Q90928077 | Improving T Cell Receptor On-Target Specificity via Structure-Guided Design |
| Q41958792 | In silico and in vitro elucidation of BH3 binding specificity toward Bcl-2 |
| Q35089640 | Integrating energy calculations with functional assays to decipher the specificity of G protein-RGS protein interactions. |
| Q40100405 | Interdomain salt-bridges in the Ebola virus protein VP40 and their role in domain association and plasma membrane localization |
| Q39210602 | Investigation on the self-association of an inorganic coordination compound with biological activity (Casiopeína III-ia) in aqueous solution |
| Q36059863 | Large-scale prediction and testing of drug activity on side-effect targets |
| Q36221173 | Low-stringency selection of TEM1 for BLIP shows interface plasticity and selection for faster binders |
| Q40995571 | MFPred: Rapid and accurate prediction of protein-peptide recognition multispecificity using self-consistent mean field theory |
| Q41103388 | Mechanistic Insights into the Binding of Class IIa HDAC Inhibitors toward Spinocerebellar Ataxia Type-2: A 3D-QSAR and Pharmacophore Modeling Approach |
| Q26801236 | Modeling for (physical) biologists: an introduction to the rule-based approach |
| Q36791136 | Molecular mechanisms and design principles for promiscuous inhibitors to avoid drug resistance: lessons learned from HIV-1 protease inhibition. |
| Q52690155 | Most yeast SH3 domains bind peptide targets with high intrinsic specificity. |
| Q30355923 | New insights into the interdependence between amino acid stereochemistry and protein structure |
| Q40839503 | New insights regarding HCV-NS5A structure/function and indication of genotypic differences |
| Q35445246 | On the electrostatic properties of homodimeric proteins |
| Q31043905 | Partner-aware prediction of interacting residues in protein-protein complexes from sequence data |
| Q33790747 | Physicochemical code for quinary protein interactions in Escherichia coli |
| Q58607157 | Pinpointed Stimulation of EphA2 Receptors via DNA-Templated Oligovalence |
| Q38814901 | Polypharmacology: in silico methods of ligand design and development |
| Q28546208 | Predicting Binding Free Energy Change Caused by Point Mutations with Knowledge-Modified MM/PBSA Method |
| Q38132466 | Promiscuity as a functional trait: intrinsically disordered regions as central players of interactomes |
| Q53395592 | Promiscuity in protein-RNA interactions: conformational ensembles facilitate molecular recognition in the spliceosome: conformational diversity in U2AF⁶⁵ facilitates binding to diverse RNA sequences. |
| Q35107384 | Promiscuous binding of Karyopherinβ1 modulates FG nucleoporin barrier function and expedites NTF2 transport kinetics |
| Q92818075 | Protein Abundance Biases the Amino Acid Composition of Disordered Regions to Minimize Non-functional Interactions |
| Q30432064 | Protein-protein alternative binding modes do not overlap |
| Q28536035 | Protein-protein interactions in a crowded environment: an analysis via cross-docking simulations and evolutionary information |
| Q58802446 | Reciprocal Perspective for Improved Protein-Protein Interaction Prediction |
| Q42550799 | Role of β-lactamase residues in a common interface for binding the structurally unrelated inhibitory proteins BLIP and BLIP-II. |
| Q93192991 | Selection of Protein-Protein Interactions of Desired Affinities with a Bandpass Circuit |
| Q30383842 | Selection on protein structure, interaction, and sequence. |
| Q28081767 | Standardization and quality control in quantifying non-enzymatic oxidative protein modifications in relation to ageing and disease: Why is it important and why is it hard? |
| Q52666816 | Stoichiometric balance of protein copy numbers is measurable and functionally significant in a protein-protein interaction network for yeast endocytosis. |
| Q64896944 | Stress-testing the relationship between T cell receptor/peptide-MHC affinity and cross-reactivity using peptide velcro. |
| Q40954391 | Structural Basis for Multi-specificity of MRG Domains. |
| Q26865027 | Structural and physico-chemical effects of disease and non-disease nsSNPs on proteins |
| Q36435139 | Structural basis for specificity and promiscuity in a carrier protein/enzyme system from the sulfur cycle |
| Q64069267 | Structural design principles that underlie the multi-specific interactions of Gα with dissimilar partners |
| Q30423652 | Structure-based redesign of the binding specificity of anti-apoptotic Bcl-x(L). |
| Q58729179 | Study of Iron, Zinc and Copper Binding Proteins of pv. : Emphasis on Secreted Metalloproteins |
| Q90245783 | T-Cell Receptor Variable β Domains Rigidify During Affinity Maturation |
| Q39375321 | Targeting high affinity and epitope-distinct oligoclonal nanobodies to HER2 over-expressing tumor cells |
| Q43420513 | The N-terminal domains of SOCS proteins: a conserved region in the disordered N-termini of SOCS4 and 5. |
| Q35062460 | The binding mechanisms of intrinsically disordered proteins. |
| Q38954693 | The coming of age of de novo protein design |
| Q28533165 | The non-structural NS1 protein unique to respiratory syncytial virus: a two-state folding monomer in quasi-equilibrium with a stable spherical oligomer |
| Q34503048 | The origins of the evolutionary signal used to predict protein-protein interactions |
| Q28484777 | The role of flexibility and conformational selection in the binding promiscuity of PDZ domains |
| Q24318515 | The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder |
| Q35333673 | Use of mechanistic models to integrate and analyze multiple proteomic datasets |
| Q30389509 | Usher syndrome: Hearing loss, retinal degeneration and associated abnormalities |
| Q41911516 | Versatility and invariance in the evolution of homologous heteromeric interfaces |
| Q28590110 | Whirlin and PDZ domain-containing 7 (PDZD7) proteins are both required to form the quaternary protein complex associated with Usher syndrome type 2 |